ADR Therapeutics, a subsidiary of Tokyo-based Cytori Cell Research Institute, Inc., has signed a Letter of Intent to collaborate with the King Abdullah International Medical Research Center on a joint clinical trial for a “90-minute complete stem cell therapy.” This partnership aims to foster medical innovation in the Middle East and offer new hope to...
